Skip to main content
. 2021 Nov 23;9(12):2414. doi: 10.3390/microorganisms9122414

Table 2.

Studies of mice inoculations with vaccine candidates.

Study Group # of
Mice/Group
Age of Mice (Weeks) Sex of Mice Prime Prime Dose (pfu or µg) Prime Adjuvant Boost Boost Dose(pfu or µg) Boost Adjuvant Bleed & Boost Schedule
(Weeks Post Prime)
1 1 4 15–20 F M PBS N/A N/A PBS N/A N/A 2—bleed
2—boost
4—bleed
4—boost
6—bleed
8—bleed
2 4 15–20 F M phiTM45 1E10 N/A phiTM45 1E10 N/A
3 4 15–20 F M phiTM45 1E11 N/A phiTM45 1E11 N/A
4 4 15–20 F M BaDAS-1 1E10 N/A BaDAS-1 1E10 N/A
5 4 15–20 F M BaDAS-1 1E10 5 µg LPS BaDAS-1 1E10 5 µg LPS
6 4 15–20 F M BaDAS-1 1E11 N/A BaDAS-1 1E10 N/A
2 1 5 8 F PBS N/A N/A PBS N/A N/A 3—bleed
3—boost
6—bleed
9—bleed
12—bleed
2 5 8 F Spike S1 20 5 µg LPS Spike S1 20 5 µg LPS
3 5 8 F phiTM45 1E11 N/A phiTM45 1E11 N/A
4 5 8 F phiTM45 1E11 5 µg LPS phiTM45 1E11 5 µg LPS
5 5 8 F BaDAS-1 1E11 N/A BaDAS-1 1E11 N/A
6 5 8 F BaDAS-1 1E11 5 µg LPS BaDAS-1 1E11 5 µg LPS
7 5 8 F BaDAS-3 1E11 N/A BaDAS-3 1E11 N/A
8 5 8 F BaDAS-3 1E11 5 µg LPS BaDAS-3 1E11 5 µg LPS
9 5 8 F BADAS-4 1E11 N/A BADAS-4 1E11 N/A
10 5 8 F BaDAS-4 1E11 5 µg LPS BaDAS-4 1E11 5 µg LPS
3 1 3 12 F M BADAS-5 5E10 N/A N/A N/A N/A 2—bleed
4—bleed
2 3 12 F M BaDAS-6 5E10 N/A N/A N/A N/A
3 3 12 F M BaDAS-7 5E10 N/A N/A N/A N/A
4 1 3 12 F BaDAS-1 5E10 N/A BaDAS-1 5E10 N/A 3—bleed
3—boost
6—bleed
9—bleed
2 3 12 F BaDAS-1 5E10 N/A Spike S1 10 N/A
3 3 12 F BaDAS-5 5E10 N/A BaDAS-5 5E10 N/A
4 3 12 F BaDAS-5 5E10 N/A Spike S1 10 N/A
5 1 3 8 F M RBD 2 2.5 µg LPS RBD 2 2.5 µg LPS 3—bleed
3—boost
6—bleed
9—bleed
6 1 3 12 F DEaDAS-1 5E9 N/A DEaDAS-1 1E11 N/A 3—bleed
6—bleed
11—boost
14—bleed
7 1 4 8 F PBS N/A N/A Spike S1 10 N/A 3—bleed
6—boost
9—bleed
2 4 8 F BaDAS-1 1E11 N/A BaDAS-1 +
Spike S1
1E11
+
10
N/A
3 4 8 F DEaDAS-1 1E11 N/A Spike S1 10 N/A